Effect of low-dose paclitaxel and docetaxel on endothelial progenitor cells

Oncology

Volumn 77, Issue 3-4, 2009, Pages 182-191

  Muta, Mariko ^a,b   Yanagawa, Tomonori ^c   Sai, Yoshimichi ^c   Saji, Shigehira ^b   Suzuki, Eiji ^b   Aruga, Tomoyuki ^b   Kuroi, Katsumasa ^b   Matsumoto, Gaku ^b   Toi, Masakazu ^d   Nakashima, Emi ^c  

^a TEIKYO HEISEI UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Docetaxel; Endothelial progenitor cells; Neovascularization; Paclitaxel; Vasculogenesis

Indexed keywords

DOCETAXEL; PACLITAXEL; TAXANE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; ENDOTHELIUM CELL; IC 50; IN VITRO STUDY; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; RAT; STEM CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA 256, WALKER; CELL LINE; CELL MIGRATION INHIBITION; CELL PROLIFERATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; RATS; RATS, WISTAR; STEM CELLS; TAXOIDS;

EID: 69549125966     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000236016     Document Type: Article

References (36)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
2. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7: 1194-1201.
3. Hilbe W, Dirnhofer S, Oberwasserlechner F, Schmid T, Gunsilius E, Hilbe G, Wöll E, Kähler CM: CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 2004; 57: 965-969.
4. Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladanyi A, Bogos K, Tovari J: Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006; 66: 7341-7347.
5. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999; 5: 434-438. (Pubitemid 29180584)
6. De Palma M, Venneri MA, Roca C, Naldini L: Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 2003; 9: 789-795.
7. Asahara T, Kawamoto A: Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 2004; 287:C572-C579. (Pubitemid 39095841)
8. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B: Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002; 2: 826-835.
9. Hortobagyi GN: Recent progress in the clinical development of docetaxel (Taxotere). Semin Oncol 1999; 26: 32-36.
10. Rose WC, Fairchild C, Lee FY: Preclinical antitumor activity of two novel taxanes. Cancer Chemother Pharmacol 2001; 47: 97-105.
11. Choy H: Taxanes in combined-modality therapy for solid tumors. Oncology 1999; 13: 23-38.
12. Miller KD, Sweeney CJ, Sledge GW Jr: Redefining the target: chemotherapeutics as antiangiogenics. J Clin Oncol 2001; 19: 1195-1206.
13. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G: The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 1996; 2: 1843-1849.
14. Vacca A, Ribatti D, Iurlaro M, Merchionne F, Nico B, Ria R, Dammacco F: Docetaxel versus paclitaxel for antiangiogenesis. J Hematother Stem Cell Res 2002; 11: 103-118.
15. Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL: Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther 2002; 1: 1191-1200.
16. Grant DS, Williams TL, Zahaczewsky M, Dicker AP: Comparison of antiangiogenic activities using paclitaxel (Taxol) and docetaxel (Taxotere). Int J Cancer 2003; 104: 121-129.
17. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S: Expression of VEGFR- 2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
18. Gehling UM, Ergün S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schäfer B, Hossfeld DK, Fiedler W: In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106-3112.
19. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL: Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol 2001; 115: 186-194. (Pubitemid 32995115)
20. Fürstenberger G, von Moos R, Lucas R, Thürlimann B, Senn HJ, Hamacher J, Boneberg EM: Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer 2006; 94: 524-531.
21. Hattori K, Muta M, Toi M, Iizasa H, Shinsei M, Terasaki T, Obinata M, Ueda M, Nakashima E: Establishment of bone marrow-derived endothelial cell lines from ts-SV40 Tantigen gene transgenic rats. Pharm Res 2001; 18: 9-15.
22. Miyata T, Iizasa H, Sai Y, Fujii J, Terasaki T, Nakashima E: Platelet-derived growth factor- BB (PDGF-BB) induces differentiation of bone marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype. J Cell Physiol 2005; 204: 948-955.
23. Muta M, Matsumoto G, Hiruma K, Saji S, Nakashima E, Toi M: Impact of vasculogenesis on solid tumor growth in a rat model. Oncol Rep 2003; 10: 1213-1218.
24. Muta M, Matsumoto G, Nakashima E, Toi M: Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: importance of monocyte chemoattractant protein-1 modulation. Clin Cancer Res 2006; 12: 264-272.
25. Hosoya KI, Takashima T, Tetsuka K, Nagura T, Ohtsuki S, Takanaga H, Ueda M, Yanai N, Obinata M, Terasaki T: mRNA expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting. J Drug Target 2000; 8: 357-370.
26. Eckardt JR: Antitumor activity of docetaxel. Am J Health Syst Pharm 1997; 54:S2-S6.
27. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S: Expression of VEGFR- 2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
28. Davidoff AM, Ng CY, Brown P, Leary MA, Spurbeck WW, Zhou J, Horwitz E, Vanin EF, Nienhuis AW: Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 2001; 7: 2870-2879.
29. Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D, Hatzopoulos AK: Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 2003; 197: 1755-1765.
30. Spring H, Schüler T, Arnold B, Hämmerling GJ, Ganss R: Chemokines direct endothelial progenitors into tumor neovessels. Proc Natl Acad Sci USA 2005;102:18111-18116.
31. Stoll BR, Migliorini C, Kadambi A, Munn LL, Jain RK: A mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapy. Blood 2003; 102: 2555-2561.
32. Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, Cheung AM, Hicklin DJ, Chaplin D, Foster FS, Benezra R, Kerbel RS: Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006; 313: 1785-1787.
33. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP: Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000; 105: 71-77.
34. Rafii S: Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 2000; 105: 17-19.
35. Fischer AN, Fuchs E, Mikula M, Huber H, Beug H, Mikulits W: PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene 2007; 26: 3395-3405.
36. Jin H, Aiyer A, Su J, Borgstrom P, Stupack D, Friedlander M, Varner J: A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest 2006; 116: 652-662.